Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice

Digestive Diseases and Sciences

Volumn 47, Issue 6, 2002, Pages 1266-1278

  Seril, Darren N ^a   Liao, Jie ^a   Ho, Kwok Lam K ^a   Warsi, Asim ^a   Yang, Chung S ^a   Yang, Guang Yu ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Carcinogenesis; Inflammation; Iron supplementation; Oxidative damage; Ulcerative colitis

Indexed keywords

DEXTRAN SULFATE; IRON;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE TIME EFFECT RELATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IRON THERAPY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ANIMALS; COLITIS, ULCERATIVE; COLON; COLORECTAL NEOPLASMS; DEXTRAN SULFATE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IRON, DIETARY; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS;

EID: 0036270885     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015362228659     Document Type: Article

References (35)

1. Inflammatory bowel disease: Etiology and pathogenesis
2. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review
3. Ulcerative colitis and colorectal cancer. A population-based study
4. Cancer morbidity in ulcerative colitis
5. Molecular mechanism for inflammation-promoted pathogenesis of cancer-the sixteenth international symposium of the Sapporo cancer seminar
6. Oral or parenteral iron treatment in chronic ulcerative colitis?
7. Genetic disorders affecting proteins of iron metabolism: Clinical implications
8. The importance of iron in rheumatoid arthritis
9. Iron supplementation may aggravate inflammatory status of colitis in a rat model
10. Iron homeostasis, oxidative stress, and DNA damage
11. Oxygen radicals in ulcerative colitis
12. Moderate elevation of body iron level and increased risk of cancer occurrence and death
13. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
14. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis
15. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: A study of histopathology, β-catenin, and p53 expression and the role of inflammation
16. Histochemical study of colonic cancer in experimental colitis of rats
17. Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium
18. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications
19. Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma
20. Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice
21. Hypothesis paper: Free radicals and the etiology of colon cancer
22. Iron metabolism in inflammation
23. Reactive oxygen species and iron-a dangerous partnership in inflammation
24. Most free-radical injury is iron-related: It is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferroxamine and apoferritin
25. The multifaceted roles of nitric oxide in cancer
26. Nitric oxide in ulcerative colitis
27. Oxidative damage and defense
28. Interaction of reactive oxygen species with DNA. A review
29. Role of oxidative DNA damage in cancer initiation and promotion
30. 4 synthesis in chronic inflammatory bowel disease
31. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis
32. Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats
33. Colorectal carcinoma associated with ulcerative colitis: A study of prognostic indicators
34. Survival with colorectal cancer in ulcerative colitis. A study of 102 cases
35. Significance and detection of dysplasia in chronic colitis